Wanxing Chai

Hematology | Oncology
100 Medical Plz Ste 550
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance.

Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance.

Journal: Leukemia & lymphoma
Published: April 15, 2026

Dynamic Targetable Extracellular Vesicle Surface Proteins Monitor Depth of Response to CAR T Therapy.

Dynamic Targetable Extracellular Vesicle Surface Proteins Monitor Depth of Response to CAR T Therapy.

Journal: Research square
Published: March 27, 2026

Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy.

Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 21, 2025

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 12, 2025

Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatment.

Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatment.

Journal: JNCI cancer spectrum
Published: March 11, 2025

Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b.

Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b.

Journal: Annals of hematology
Published: March 06, 2025

Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.

Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.

Journal: Blood advances
Published: February 24, 2025

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies.

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies.

Journal: Nature communications
Published: November 25, 2024

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.

Journal: BMC cancer
Published: August 28, 2024

Improved Survival of Advanced-Stage Anaplastic Thyroid Cancer With Systemic Therapy.

Improved Survival of Advanced-Stage Anaplastic Thyroid Cancer With Systemic Therapy.

Journal: The Laryngoscope
Published: February 08, 2024

Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma.

Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma.

Journal: Nano today
Published: December 01, 2023

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 13, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026